Phase 1 data suggest senotherapeutic activity in

Novo Nordisk’s higher-dose semaglutide arrives

Human Longevity and LEV Foundation will study ce

Cellbricks Therapeutics has raised €10 million

Alina M Hernandez and Nigel Franklyn on why long

Maze Therapeutics announced positive topline Phas

Human Longevity, Inc.

Rubedo Life Sciences reported preliminary Phase 1

Fresh funding backs a high-stakes attempt to do

SEMCAP is betting that longevity’s next growth

Immortal Dragons-backed Unlimited Bio registers

New data link popular weight-loss drugs to highe

Deal worth up to $150m comes as supplementation

20/20 BioLabs has entered an exclusive U.S.

Anavex Life Sciences withdrew its marketing autho

Cognito Therapeutics and Ochsner Health have laun

SpectraCell Laboratories introduced Baseline Nexu

Roatán-based longevity clinic adds Klotho to it

Combined company targets mitochondrial biology a

Cognito and Ochsner join forces to explore how c

As longevity biotech scales, new AI tools target

Fresh Alzheimer’s theory gives investors new l

New profiling tech looks beyond which microbes l

Longevity Medical Institute’s new paper adds w

Celosia Therapeutics announced on 23 March 2026,

C2N Diagnostics reported the first application of

Nanoscope Therapeutics announced publication of a

Annovis has partnered with NeuroRPM to deploy an

Alnylam is launching coordinated initiatives to a

Preprint RCT in healthy adults suggests multi-ta

Partners expand beyond initial sarcopenia progra

New tool harnesses data from multiple sources to

New preclinical data suggest Galimedix may have

Company aims to give AI much broader map of life

Anavex Life Sciences presented new data from its

NeuroRPM’s FDA-cleared wearable platform will b

ProMIS Neurosciences presented two scientific pos

Unlimited Bio registered a Phase 1/2a clinical tr

Fauna Bio announced the designation of a target u

Garm LLC, doing business as Longevity Advanced, u

RevGenetics launched DiBerberine 300x, an enteric

A peer-reviewed study published in March 2026 by

Elitra Health announced on 20 March 2026 that it

Why aging science built around male biology keep

New study shows Gen X and Millennials face risin

New precompetitive effort aims to standardize ho

Results suggest ABBV-295 could expand the next g

Daily oral PCSK9 drug could make powerful heart

Swedish biotech doses first subjects in new ATR-

Fresh funding will help Cambridge startup turn v